IKS • Health Care
ROCE
40.66%
FY24 Actual
D/E Ratio
0.48
Leveraged
5Y Rev CAGR
41.4%
High Growth
Profit Margin
| Metrics (Values in Cr) | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | TTM |
|---|---|---|---|---|---|---|
| Total Revenue | 784.46 | 1,060.16(+35.1%) |
23.8%
5Y Average
2,702.99(+45.5%) |
3,210.98(+18.8%) |
3,210.99 |
| Operating Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| Operating Profit | — | — | — | — | — | — |
| Raw Profit | 0 | 0 | 0 | 0 | — | — |
| Operating Expenses | 50.98 | 82.35(+61.5%) | 136.53(+65.8%) | 202.63(+48.4%) | 2,111.67(+942.1%) | 2,111.67 |
| Selling General And Administrative Expenses | 59.84 | 92.86(+55.2%) | 192.52(+107.3%) | 187.58(-2.6%) | — | — |
| Depreciation And Amortization | 23.31 | 24.55(+5.3%) | 58.55(+138.5%) | 112.66(+92.4%) | 124.15(+10.2%) | 124.15 |
| Profit Before Interest | 275.67 | 365.39(+32.5%) | 502.75(+37.6%) | 697.71(+38.8%) | 975.16(+39.8%) | 975.17 |
| Interest Expense | 7.15 | 6.05(-15.4%) | 61.08(+909.6%) | 91.43(+49.7%) | 70.25(-23.2%) | 70.25 |
| Profit Before Tax | 268.52 | 359.34(+33.8%) | 441.67(+22.9%) | 606.28(+37.3%) | 904.91(+49.3%) | 904.92 |
| Tax Expense | 35.55 | 54.11(+52.2%) | 71.18(+31.5%) | 120.23(+68.9%) | 183.36(+52.5%) | 183.37 |
| Net Income | 232.97 | 305.23(+31.0%) | 370.49(+21.4%) | 486.05(+31.2%) | 721.55(+48.5%) | 721.55 |
| Earnings Per Share | 13.849 | 17.848(+28.9%) | 21.681(+21.5%) | 28.386(+30.9%) | 43.12(+51.9%) | 42.055 |
| Dividends Per Share | 54.5 | 10(-81.7%) | 0(-100.0%) | 0 | 0 | 0 |
| Payout Ratio | 3.935 | 0.56(-85.8%) | 0(-100.0%) | 0 | 0 | 0 |